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ABSTRACT
Although XRN2 proteins are highly conserved eu-
karyotic 50!30 exonucleases, little is known about
their function in animals. Here, we characterize
Caenorhabditis elegans XRN2, which we find to be
a broadly and constitutively expressed nuclear
protein. An xrn-2 null mutation or loss of XRN2 cata-
lytic activity causes a molting defect and early larval
arrest. However, by generating a conditionally
mutant xrn-2ts strain de novo through an approach
that may be also applicable to other genes of
interest, we reveal further functions in fertility,
during embryogenesis and during additional larval
stages. Consistent with the known role of XRN2 in
controlling microRNA (miRNA) levels, we can dem-
onstrate that loss of XRN2 activity stabilizes some
rapidly decaying miRNAs. Surprisingly, however,
other miRNAs continue to decay rapidly in xrn-2ts
animals. Thus, XRN2 has unanticipated miRNA spe-
cificity in vivo, and its diverse developmental func-
tions may relate to distinct substrates. Finally, our
global analysis of miRNA stability during larval stage
1 reveals that miRNA passenger strands (miR*s) are
substantially less stable than guide strands (miRs),
supporting the notion that the former are mostly
byproducts of biogenesis rather than a less
abundant functional species.
INTRODUCTION
XRN2 proteins constitute a family of eukaryotic 50!30
exoribonucleases that have various RNA substrates (1).
For instance, in yeast, where XRN2 has been particularly
well studied and is commonly known as Rat1p, it is
involved in processing of ribosomal RNAs and small
nucleolar RNAs (2–6), transcriptional termination (7)
and degradation of aberrant transfer RNAs (8), among
other functions. The diversity of substrates in vivo is re-
ﬂected by relaxed substrate speciﬁcity in vitro where Rat1p
processively degrades 50 monophosphorylated RNAs that
lack strong secondary structures to mononucleotides
(9,10). The catalytic site of XRN2/Rat1p contains seven
acidic amino acids, which form a pocket for a divalent
cation (Mg2+ or Mn2+) required for the exoribonuclease
activity (11).
A paralogous enzyme, Xrn1p, exists in the yeast cyto-
plasm (12), where it is involved in degradation of decapped
mRNAs (13). Single orthologues of XRN1 and XRN2,
respectively, are also found in animals, and it is assumed
that distinct localization and the resulting division of labor
that characterize yeast Xrn1p and Rat1p (14) also apply to
their orthologues in other organisms, although this has not
yet been investigated systematically. A nuclear localization
signal present in Rat1p is not conserved in XRN2
orthologues of other species (14), but nuclear RNAs such
as pre-mRNAs and 5.8S and 18S ribosomal RNAs have
been reported as common substrates of XRN2 in yeast and
other species [reviewed in (15)]
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In Caenorhabditis elegans, the single XRN2-type pro-
tein was found to function in degradation of mature
microRNAs (miRNAs) (16). These short (22 nt) non-
coding RNAs are derived from longer precursor tran-
scripts, from which two successive processing steps
release a 22 nt duplex RNA consisting of an miRNA
guide (miR) bound to an miRNA passenger (miR*)
strand (17). This duplex is loaded onto an Argonaute
protein and the guide strand retained, whereas the passen-
ger strand is released and presumably discarded. The des-
ignation of miR and miR* was initially based on their
relative abundance, with the more abundant strand
assumed functional and thus designated miR. However,
individual miR*s have also been shown to be functional
[reviewed in (18)], so that in recent times the use of two
sufﬁxes indicating the ‘arm’ of the precursor transcript
from which an miRNA is derived, i.e. 3p or 5p, has
become more common. At any rate, miRNA-Argonaute
complexes can bind to partially complementary sequences
in 30-untranslated regions (30-UTRs) of mRNAs to repress
their translation and induce their degradation (19). They
thus regulate a large number of genes, affording them,
as a class, important roles in animal development and
pathology (20).
Two lines of evidence support a function of XRN2 in
the degradation of mature miRNAs (16). First, C. elegans
lysates containing wild-type levels of XRN2 were more ac-
tive in decay of naked synthetic and Argonaute-associated
miRNAs than XRN2-depleted lysates. Second, depletion
of XRN2 by RNA interference (RNAi) yielded increased
steady-state levels of a number of endogenous miRNAs.
In these latter experiments, however, the levels of some
miRNAs were unchanged. Because RNAi may be inefﬁ-
cient in certain tissues or at certain times, it remained
unknown whether this reﬂected true substrate speciﬁcity
or a technical limitation of the experiment.
Despite prominent molecular functions, the roles
of XRN2 in animal development largely remain to be
explored (15). In mice and humans, over-expression of
XRN2 has been implicated as a risk factor for a speciﬁc
type of lung cancer (21), but a molecular basis remains to
be established. In C. elegans, XRN2, encoded by the xrn-2
gene, was found in a genome-wide RNAi screen for factors
involved in molting (22), the process in which worms syn-
thesize a new and shed their old cuticle. Molting occurs
once at the end of each of the four larval stages, L1
through L4, (23) and Frand et al. (22) found that xrn-2
depleted animals were unable to shed the cuticle from the
pharynx at the ﬁnal (L4) molt. Consistent with this pheno-
type, a putative xrn-2 promoter, with only limited spatial
activity as assayed by a Green Fluorescent Protein (GFP)
reporter, was active in myoepithelial cells that secrete the
pharyngeal cuticle (22). Promoter activity also occurred in
other cells implicated in molting, including a particular
pharyngeal neuron and intestinal cells. How XRN2
affects molting is unknown, although this function may
involve regulation of expression of MoLTing Defective
10 (MLT-10), another molting factor, in a direct or
indirect manner, through an unknown mechanism. RNAi
against xrn-2 also causes slow growth and sterility (16), but
again the basis of these phenotypes remains unknown.
To obtain a better understanding of the developmental
functions of XRN2 and its role in miRNA turnover, we
have characterized xrn-2 null mutant C. elegans. We ﬁnd
that these animals arrest at the L2 stage, following a failed
molt from the L1 to the L2 stage. The unanticipated
ability to complete embryogenesis was not due to the
absence of an essential embryonic function of XRN2,
but reﬂected masking of the null phenotype due to
maternal contribution. We demonstrate this through an
xrn-2ts allele, which we generated by transplanting condi-
tional mutations from yeast to C. elegans. We can thus
show that XRN2 is essential during several stages of
C. elegans development, including embryogenesis. These
broader functions are consistent with a revised picture of
xrn-2 expression that we obtained using a rescuing trans-
gene and detection of the endogenous protein by western
blotting. Using small RNA deep sequencing to determine
miRNA decay rates, we ﬁnd that miR*s are generally less
stable than miRs. Strikingly, among the small group of
unstable miRs, only some become stabilized by inactiva-
tion of XRN2. We conclude that XRN2 has unanticipated




Caenorhabditis elegans strains were cultured by standard
methods described previously (24). The Bristol N2 strain
was used as wild-type. Animals heterozygous for xrn-
2(tm3473) were obtained from Dr Shohei Mitani, back-
crossed three times and balanced. Strains used are shown
in Supplementary Table S1.
Cloning and site-directed mutagenesis
Cloning and site-directed mutagenesis were performed by
PfuUltra II Fusion HS DNA Polymerase (Agilent
Technologies, Santa Clara, CA, USA) according to the
supplier’s protocol using speciﬁc primers (Supplementary
Table S2). The codon-optimized xrn-2 with three artiﬁcial
introns (Supplementary Table S3) was designed according
to a previous report (25) and synthesized using a commer-
cial service (GenScript, Piscataway, NJ, USA).
Single-copy transgene insertion
DNA fragments were inserted into pCFJ210 (for chromo-
some I) or pCFJ201 (for chromosome IV) vectors by
Multisite Gateway Technology (Life Technologies,
Carlsbad, CA, USA) according to the supplier’s
protocol. Mos1-mediated single-copy transgene insertion
was performed according to previous reports (26,27).
Following conﬁrmation of correct insertion by polymerase
chain reaction (PCR), transgenic strains were backcrossed
at least three times to the N2 strain.
Multicopy transgene arrays
The multisite gateway cloning system (Invitrogen) was
used to insert transgenes into the pCG150 destination
vector (containing unc-119 rescuing fragment), which
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was transformed into young adult unc-119(ed3) worms by
microparticle bombardment using the Biolistic PDS-1000/
He particle delivery system (BioRad) (28). For each
bombardment, 16 ml of 0.5 mg/ml pCG150 and 4 ml of
0.8mg/ml pCFJ90 (co-injection marker containing Pmyo-
2::mCherry) were coupled to 1-mm microcarrier gold
beads (BioRad, Cat#165-2263). Worms were allowed to
recover for 1 h at 15C after bombardment and were then
grown at 25C on NG 2% plates seeded with OP50
bacteria for ca. 2 weeks before screening for wild-type
moving worms and mCherry-ﬂuorescence from the co-in-
jection marker. Transgenes containing wild-type or
D234A-D236A double mutant xrn-2 sequences were
stably transmitted and expressed in the germline, suggest-
ing integration into the genome.
Antibodies and western blotting
Recombinant full-length C. elegans XRN2 was prepared
as described (16) and used to immunize rats (Charles River
Laboratories, Kisslegg, Germany), to obtain an anti-
XRN2 antibody. A mouse monoclonal anti-actin
antibody (clone C4) was purchased from Millipore
(Billerica, MA, USA). The anti-XRN2 antibody and
anti-actin antibody were used with 1000- and 3000-fold
dilutions, respectively, followed by horseradish peroxid-
ase-conjugated secondary antibody (GE Healthcare,
Little Chalfont, UK) reaction. The membranes were
treated with ECL Western Blotting Detection Reagents,
and protein bands were detected using Amersham
Hyperﬁlm ECL (Figure 3C) or by an ImageQuant LAS
4000 hemiluminescence imager (all GE Healthcare)
(Figure 4C). Band intensities were quantiﬁed using the
ImageJ software (NIH, Bethesda, MD, USA).
Microscopy
Differential Interference Contrast (DIC) and ﬂuorescent
images were obtained using an Axio Observer Z1 micro-
scope and AxioVision SE64 (release 4.8) software (Carl
Zeiss, Oberkochen, Germany). Stereoscopic images were
obtained by M205 A stereo microscope (Leica, Solms,
Germany).
RNA preparation, sequencing and RT-qPCR
Gravid N2 or xrn-2ts worms were treated with bleaching
solution [30% sodium hypochlorite (5% chlorine) reagent
(Thermo Fisher Scientiﬁc, Waltham, MA, USA), 750mM
potassium hydroxide] to extract eggs, which were then
incubated in M9 medium overnight to hatch. The resulting
synchronized L1 larvae were cultured with Escherichia coli
OP50 in S-medium supplemented with trace metal
solution (29) at a concentration of 1 104 worms/ml
with shaking (180 rpm) at 25C for 2 h. Subsequently,
a-amanitin (Sigma-Aldrich, St. Louis, MO, USA) was
added to a ﬁnal concentration of 50 mg/ml, which
blocks transcription and stalls larval development
(Supplementary Figure S2). A total of 1.5 104 worms
were harvested at each sampling time point during the
next 8 h, washed three times with M9 medium, resus-
pended in 700 ml of TRIzol reagent (Life Technologies)
and frozen in liquid nitrogen. Worms were broken open
by ﬁve repeats of freeze and thaw using liquid nitrogen
and a 42C heating block, before RNA was extracted and
puriﬁed according to the supplier’s protocol with the
modiﬁcation that RNA was incubated with 50%
2-propanol at 80C overnight for efﬁcient precipitation
of small RNA.
Small RNA (15–30 nt) libraries were prepared from
extracted total RNA using TruSeq Small RNA Sample
Prep Kit (Illumina, San Diego, CA, USA) according to
the supplier’s protocol. All samples were multiplexed and
13 pM of the multiplexed libraries sequenced on two lanes
of an Illumina HiSeq 2000 instrument using RTA 1.13.48.
Individual reads were assigned to their sample based on
the TruSeq barcode using the Illumina software Casava
v1.8.0.
Quantiﬁcation of individual miRNAs by reverse
transcription-quantitative polymerase chain reaction
(RT-qPCR) was done using TaqMan MicroRNA Assays
(Life Technologies) and StepOnePlus Real-time PCR
Systems (Applied Biosystems, Foster City, CA, USA) ac-
cording to the suppliers’ protocols. Forty nanogram of
total RNA was used as a template for reverse transcrip-
tion reaction (15 ml), and 1.3 ml of the reaction was used
for qPCR reaction (25 ml). The miRNA levels were
normalized to the small nucleolar RNA sn2841 levels.
For mRNA quantiﬁcation, complementary DNA
(cDNA) was generated from total RNA by ImProm-II
Reverse Transcription System (Promega, Fitchburg, WI,
USA) using oligo(dT)15 primers (for Figure 4D) or
random primers (for Supplementary Figure S2B, C)
according to the supplier’s protocol. RT-qPCR was per-
formed with speciﬁc primers (Supplementary Table S2), a
SYBR Green PCR Master Mix (Applied Biosystems) and
a StepOnePlus Real-time PCR System. Primer sequences
for pre-eft-3 mRNA and 18S ribosomal RNA were taken
from (30) and (31), respectively.
Analysis of the miRNA sequencing data
For each read, the 30 adaptor TGGAATTCTCGGGTGC
CAAGG was removed by aligning it to the read allowing
one or two mismatches in preﬁx alignments of at least 7 or
10 bases, respectively. Reads with low complexity were
ﬁltered out based on their dinucleotide entropy
(removing <1% of the reads). Only reads with a
minimum length of 14 nt were retained. Alignments to
the miRNA database miRBase release 18 (http://www.
mirbase.org/) were performed by the software bowtie
(version 0.9.9.1) (32) with parameters -v 2 -a -m 100,
tracking up to 100 best alignment positions per query
and allowing at most two mismatches. Reads that
mapped to a miRNA but at the same time also mapped
with fewer mismatches to the genome (ce6) were ﬁltered
out. The expression of each miRNA was determined by
counting the number of associated reads. To compensate
for differences in the read depths of the individual
libraries, each sample was divided by its total number of
counts and multiplied by the average sample size. The re-
sulting values were log2 transformed using a pseudo-count
of 1 (y= log2(x+1)). To obtain relative decay rates for the
time window t=1h to t=8h, the change in expression of
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each miRNA over time was determined by the slope of a
linear ﬁt performed in R (www.r-project.org). Slopes for
the two replicates were calculated separately and then
averaged for further use.
Release 18 of miRBase does no longer provide identi-
ﬁers that label a miRNA as a mature or a star form. We
thus identiﬁed the star forms by ﬁrstly pairing the 5p and
3p forms using the miRNA name (without the 5p and
3p extensions) and then assigning the star label to the
form with the lower expression level in the untreated
sample.
Determination of miRNA half-life
We assumed miRNAs to decay exponentially according to
the following equation:
N tð Þ ¼ N0  2t=
where t is the time, N(t) is the concentration of the
miRNA at time point t, N0 is the starting concentration
and t is the half-life of the miRNA.
From this follows a linear relationship between the
logarithmic concentration (measured as delta-Ct values)
and the half-time t:
log2 N tð Þð Þ ¼ 1=ð Þ  t+log2 N0ð Þ
t can be obtained from the slope of a linear regression
by the following equation:
 ¼ 1=slope
The intercept term captures differences in the starting
concentration; for visualization, the term was subtracted
from delta-Ct values.
The miRNA half-lives were calculated for individual
replicate experiments. The half-life of stable miRNAs
that decreased <20% (the detection limit) over the
course of the 8-h experiment was set to 30 h, which is
the t resulting from a 20% decrease in 8 h and corresponds
to a lower limit estimate for the half-life of such miRNAs.
The signiﬁcance of differences in half-lives between
worm strains was calculated using a two sample t-test
assuming equal variances.
RESULTS
tm3473 is a bona ﬁde null allele of xrn-2
Previous studies on xrn-2 mutant phenotypes relied on its
depletion by RNAi (16,22). However, knock-down of
genes by RNAi is usually incomplete and may vary
across tissues. Therefore, we set out to characterize the
xrn-2 mutant xrn-2(tm3473), provided by Dr Shohei
Mitani. The tm3473-allele is a deletion of 278 bases in
exon 3 leading to a frame shift at amino acid position
278 and a premature stop codon at position 308
(Figure 1A). Western blotting using an antibody against
XRN2 conﬁrmed absence of full-length XRN2 protein in
the xrn-2(tm3473) background (Figure 1B). This strain,
and a wild-type strain included for comparison, contains a
transgene to express full-length GFP-tagged XRN2 to
achieve wild-type development (see later in the text). We
also failed to detect a band corresponding to the predicted
size of a potential truncated translation product (data
not shown). Although we cannot formally exclude that
the polyclonal antiserum that we used would fail to
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Figure 1. xrn-2(tm3473) is a bona ﬁde null allele that causes molting
defects and developmental arrest. (A) Schematic representation of wild-
type and mutant XRN2. Conserved regions are shown in light grey.
Dark grey indicates sequence unique to the xrn-2(tm3473) mutant due
to a frame shift. Point mutations investigated in this study are
indicated. (B) Western blotting conﬁrms absence of endogenous
XRN2 in the xrn-2(tm3473) background (lane 3). xrn-2(+) denotes
the N2 wild-type strain. Note the presence of an XRN2/GFP-
encoding transgene in the strains shown in lane 2 and 3, used to
restore development of the xrn-2(tm3473) mutant strain. (C) DIC
micrographs of worms grown at 25C; gonads are outlined to facilitate
staging. (i, ii) After 18 h, both xrn-2/+ (tm3473 heterozygous) and
xrn-2/xrn-2 (tm3473 homozygous) worms are at the L2 stage. (iii, iv)
After 29 h, xrn-2/xrn-2 worms remain arrested at the L2 stage (iv),
whereas the heterozygous siblings have reached the L4 stage (iii).
(v, vi) Larval arrest is accompanied by molting defects. xrn-2/xrn-2
worms are unable to shed the pharyngeal cuticle (v, arrow head),
which leads to superposition of the old and newly synthesized cuticle
(vi, arrow heads). Scale bar, 20 mm.
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cross-react with such a truncated product despite the fact
that it was raised against recombinant full-length protein,
the data suggest that the mutant mRNA may be degraded
through nonsense-mediated decay. We conclude that xrn-
2(tm3473) is a bona ﬁde null allele.
xrn-2(0) mutant animals fail to molt and arrest during L2
Worms exposed to xrn-2(RNAi) from L1 stage arrest
as L4 larvae that are unable to ecdyse, i.e. shed the
cuticle (22). By contrast, xrn-2(tm3473) animals al-
ready displayed penetrant defects in the L1-to-L2 molt
(Figure 1C), the ﬁrst molt during development. Ecdysis
starts with loosening of the cuticle at the pharynx
followed by rotations around the longitudinal axis that
loosen the body cuticle (33). XRN2 appears to be
involved in the early shedding of the cuticle taking place
at the pharynx as the mouth of worms homozygous for
tm3473 remained attached to the old cuticle through a
string-like structure [Figure 1C(v)]. The rest of the
cuticle around the head and the body was at least partially
detached [Figure 1C(v and vi)], and a new cuticle was
already visible beneath the old one, indicating that
XRN2 is predominantly involved in ecdysis rather than
cuticle synthesis. Finally, following failure to shed the
L1 cuticle, and possibly as a direct consequence (33), the
mutant worms arrested during the L2 stage [Figure 1C(iv
and iii)].
XRN-2 catalytic activity is required for molting
Although XRN2 is an RNase, it was not evident that the
RNase activity was actually required for the developmen-
tal functions of this protein. XRN1 and XRN2 proteins
share a conserved three amino acid motif, DXD, that is
essential for exonuclease activity in vivo (11,34). The
aspartic acids (D) in this motif are important for
coordination of Mg2+ ions that are required for RNA
hydrolysis. We thus constructed cDNA-based transgenes
that encoded either the wild-type XRN2 or the catalytic
dead D234A-D236A double mutant protein, where A
stands for alanine. Both transgenes were driven from a
promoter region covering 1.4 kb of upstream sequence
and carried the xrn-2 30-UTR as well as a C-terminal
triple GFP/His6/Flag-tag (Figure 2). As expected, the
wild-type transgene efﬁciently rescued both the molting
defect and larval arrest when introduced as a stable
multicopy array (Figure 2C). By contrast, the mutant
transgene was incapable of rescuing molting defect and
larval arrest (Figure 2D), although mutant and wild-type
protein accumulated at equivalent levels in vivo (Figure
2E). We conclude that the RNase activity of XRN2 is
essential for its function in early larval development.
xrn-2 is expressed broadly and constitutively
Frand et al. (22) previously analysed the ability of a 132bp
sequence upstream from the xrn-2 start codon to drive
expression of gfp when present in a multicopy extrachromo-
somal array, and concluded that xrn-2 expressionwas limited,
occurring mostly in the pharyngeal myoepithelium, the intes-
tine and certain neurons. This seemed surprising given that,
based on our understanding of yeast and human Rat1p/
XRN2 proteins, C. elegans XRN2 would be expected to be
broadly involved in RNA processing and decay processes.
Moreover, theWormbase database annotates xrn-2 as the se-
cond gene in a two-gene operon where rpl-43 is the upstream
gene, 132bp away (Figure 3A). In generating the rescuing
transgene described earlier in the text, we had therefore
used an extended sequence of 1413bp upstream of the
xrn-2 start codon, reaching the 5’-end of the Y48B6A.1
ORF (Figure 3A). This construct revealed widespread,
possibly ubiquitous expression, with XRN2/GFP signal
A xrn-2(+) B xrn-2/xrn-2
















Figure 2. XRN2 catalytic activity is required for molting and growth beyond the L2 stage. (A) Wild-type worms develop into gravid adults, whereas
(B) xrn-2(tm3473) homozygous worms arrest development. (C) Transgenic extrachromosomal xrn-2 expressed under the control of the xrn-2 1413-bp
promoter and xrn-2 30-UTR rescues xrn-2(tm3473) mutant animals, whereas (D) a catalytically inactive version of xrn-2 with two point mutations
(D234A and D236A) does not. Both transgenes contain a C-terminal GFP tag, permitting their detection with an anti-GFP antibody. (E) Western
blotting reveals equivalent accumulation of wild-type (lane 1) and mutant (lane 2) protein in vivo. Scale bar, 50 mm. xrn-2(+) denotes the N2 wild-
type strain.
4060 Nucleic Acids Research, 2014, Vol. 42, No. 6
being detectable from early embryo through adulthood
(Figure 3B). This expression was further validated through
a time course that followed endogenous XRN2 protein by
western blotting, and equally revealed continuous xrn-2
expression throughout the C. elegans life cycle (Figure 3C).
Complementation of mutant phenotypes can provide a
functional test for the authenticity of a putative promoter,
and we found that xrn-2 transgenes driven by the xrn-2
‘long’ promoter could rescue the xrn-2(tm3473) strain.
This was true both when xrn-2 cDNA was used
(Figure 2C), which resulted in protein levels that were
reduced relative to the endogenous protein (Figure 1B),
and when a codon-optimized variant with synthetic
introns was used (Figure 3D), which generated protein
levels more similar to endogenous levels (see later in
the text). By contrast, the xrn-2 ‘short’ promoter failed
to rescue the xrn-2(tm3473) mutation, although the
optimized transgene was used (Figure 3D). Taken
together, our results demonstrate that xrn-2 is expressed
broadly, perhaps ubiquitously, across tissues and
developmental stages, and that expression beyond previ-
ously reported tissues is important for its role in molting.
A xrn-2 temperature-sensitive allele generated de novo
reveals additional XRN2 functions
Our ﬁnding of a molting defect as the predominant pheno-
type of xrn-2 null mutant animals was consistent with a pre-
viously reported molting defect in xrn-2(RNAi) animals
(22). However, given the broad expression of XRN2,
which extends to the embryo, we wondered whether
earlier phenotypes were obscured due to maternal contri-
bution of mRNA or protein from xrn-2/+ heterozygous
mothers to their xrn-2/xrn-2 homozygous daughters.
Rapidly inactivatable, conditional alleles would permit
addressing this issue, but such alleles can currently not be
generated in a targeted manner, for a speciﬁc gene of
interest, in C. elegans. However, temperature-sensitive (ts)
alleles have been described in Saccharomyces cerevisiae
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*
Figure 3. XRN2 is ubiquitously and constitutively expressed. (A) Schematic depiction of the xrn-2 genomic locus and promoters used. The arrows
indicate the direction of transcription. (B) Micrographs showing GFP signal of single-copy-integrated, codon-optimized and gfp-tagged xrn-2
expressed under the control of the 1413-bp long promoter region. The GFP signal is ubiquitously detected. Examples of hypodermal and intestinal
cells are marked with arrowheads. Insets: DIC images of the same worms. (C) Western blot showing a time-course for endogenous XRN2. ‘e’, ‘m’
and ‘l’ stands for early, mid and late, respectively; ‘YA’ and ‘GA’ for young and gravid adult, respectively. An asterisk indicates an apparent
proteolytic fragment of XRN2, which did not occur consistently in other western blots. (D) Single-copy-integrated, codon-optimized and gfp-tagged
xrn-2 expressed under the control of the 1413-bp long xrn-2 promoter region rescues the phenotypes of xrn-2(tm3473), but the 132-bp long xrn-2
promoter region does not. Scale bar, 20 mm (B) and 50 mm (D).
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(36). Individual mutation of either aspartate of the DXD
motif mentioned earlier in the text to alanine (A) may
further impair but not abrogate Mg2+ binding and ren-
der the protein function ts (34). We thus went to
test whether the corresponding mutations in C. elegans
xrn-2-elicited temperature sensitivity within the worm’s
physiological temperature window, 10C below that of
yeast. We introduced single-copy integrated xrn-2 trans-
genes with appropriate mutations into strains that were
homozygous for xrn-2(tm3473), i.e. lacked endogenous
XRN2. Among three distinct mutations that we tested
(Figure 1A), P107L, corresponding to S. cerevisiae
xrn1-10(P90L) (36), conferred temperature sensitivity,
supporting viability at 15C but not at 25C. By contrast,
a Y594C-mutant transgene supported viability at either
temperature, whereas the D234A mutant transgene
rescued at neither temperature. In the following, we will
refer to the mutant strain that expresses xrn-2P107L as
xrn-2tscDNA to distinguish it from an optimized version
described later in the text. An analysis of different tempera-
ture regimens revealed numerous phenotypes of xrn-
2tscDNA animals beyond the molting defect observed with
the xrn-2 null strain, including arrest in embryonic devel-
opment and sterility (Supplementary Figure S1). These
mutant strains thus revealed multiple functions of XRN2
beyond molting, which had been obscured in the null
mutant animals.
Although the xrn-2tscDNA transgene permitted
rapid and tight inactivation of xrn-2 (Supplementary
Figure S1), it failed to provide full XRN2 activity at the
permissive temperature as illustrated by slow growth and
small brood sizes small (25 relative to 250 for wild-type
animals) relative to wild-type animals. This reduced the
strain’s utility for molecular or biochemical studies or
genetic screens. Because low-protein levels relative to the
endogenous protein (Figure 1B) might account for the
reduced functionality, we introduced artiﬁcial introns
into the xrn-2 cDNA and optimized its codon composition
(25). For the wild-type protein, these nucleotide changes
increased XRN2/GFP levels as determined by epiﬂuores-
cence microscopy (data not shown). Moreover, xrn-
2(tm3473) animals expressing the sequence-optimized
xrn-2P107L::gfp single-copy transgene, which we will
henceforth call xrn-2ts, grew better (although still more
slowly than wild-type animals) and had an increased
brood size. At the same time, we could still rapidly and
efﬁciently inactivate the optimized transgene by raising the
temperature (Figure 4A, B), although a fully penetrant
embryonic or L1 arrest now necessitated incubation at
26C, rather than 25C. Viability and development
of N2 wild-type animals remained unimpaired at this tem-
perature (Figure 4B) (37).
The P107L mutation induces temperature sensitivity by
reducing XRN2 stability
To test whether destabilization of the protein by elevated
temperature contributed to the ts behavior of xrn-2P107L,
we examined steady-state levels of XRN2 at 15 and 26C.
We observed that XRN2 levels were substantially lower in
the xrn-2ts mutant strain than either N2 or a strain
carrying the wild-type transgene (Figure 4C). We note
that wild-type XRN2/GFP levels were also reduced
relative to endogenous XRN2 concentration in N2, par-
ticularly at 26C, but the decrease was less than that seen
with XRN2P107L/GFP. Hence, it seems likely that the
P107L mutation renders XRN2 ts by destabilizing it, con-
sistent also with its location directly adjacent to an unusu-
ally long a-helix, previously termed ‘tower domain’ (11).
To test this possibility further, we quantiﬁed xrn-2 mRNA
levels in the two xrn-2 transgenic strains. Unlike XRN2
protein levels, the xrn-2 mRNA levels were not reduced in
the mutant strain. In fact, xrn-2ts mRNA accumulated at
increased concentrations relative to the wild-type mRNA,
particularly at 26C (Figure 4D). Hence, these results not
only conﬁrm that the P107L mutation causes temperature
sensitivity by reducing XRN2 protein stability but also
indicate the existence of an auto-regulatory mechanism
that promotes transcription or stabilization of xrn-2
mRNA when XRN2 activity is low.
The miR* strands decay more rapidly than guide strands
Our previous studies (16,38) had implicated C. elegans
XRN2 in miRNA turnover by revealing increased
steady-state levels of certain endogenous miRNAs in
xrn-2(RNAi) worms and XRN2-dependent degradation
of naked or Argonaute-loaded miRNAs in worm lysates.
However, a formal demonstration that XRN2 depletion
slowed miRNA degradation in vivo was missing.
Moreover, certain endogenous miRNAs appeared un-
changed on XRN2 depletion, but whether due to substrate
speciﬁcity, or technical limitations, e.g. in the kinetics or
tissue distribution of RNAi-mediated XRN2 depletion,
remained unknown. To address these two issues, we
examined miRNA decay globally in vivo in wild-type N2
animals. We performed a time-course experiment in which
we inhibited transcription in L1 stage larvae by addition
of a-amanitin (Supplementary Figure S2) and surveyed
miRNAs at several subsequent time points over the next
8 h by deep sequencing (Figure 5A). We chose the L1 stage
because these larvae had previously been reported to be
sensitive to treatment with a-amanitin (39), and we con-
ﬁrmed that this treatment efﬁciently blocked transcription
by assaying eft-3 pre-mRNA levels (Supplementary Figure
S2B, C). For each time point, we calculated the levels of
each miRNA as reads normalized to average library size
(‘Materials and Methods’ section), which means that these
numbers can go up or down or stay unchanged for a given
miRNA depending on whether it decays less rapidly, more
rapidly or just as rapidly as the average miRNA in this
pool. Accordingly, the fold changes per hour in log2 can
be positive, negative or 0, with negative values indicating
less stable miRNAs. However, these values cannot be
translated into absolute decay rates.
The fold changes per hour thus calculated for two
independent biological replicates correlated well
(Supplementary Figure S3) and their averages were used
for subsequent analysis. A scatter plot displaying fold
changes versus read numbers revealed that decay rates
were broadly distributed with a subset of miRNAs dis-
playing a strikingly faster decay than average (Figure
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5B). The effect was particularly pronounced for miRNAs
of lower abundance. Strikingly, when we coloured miR*s,
operationally deﬁned as the one of two miRNA strands
derived from a pre-miRNA that is less abundant, in red,
and miRs in black, a clear separation of colours became
apparent (Figure 5B). Hence, highly unstable RNAs were
almost exclusively miR*s (Figure 5B). This result makes
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Figure 4. Characterization of an improved xrn-2ts strain reveals reduced XRN2 levels at restrictive temperature. (A) Schematic representation of
xrn-2ts phenotypes at different temperature. xrn-2ts embryos or worms were cultured under the indicated conditions. Phenotypes observed are
described on the right. For less-penetrant phenotypes, a number indicating worms affected/worms scored is shown in brackets. (B) The wild-type
(‘wt’; N2) and xrn-2ts worms were cultured from L1-stage at 20 or 26C as indicated for 72 h (wt) and 93 h (xrn-2ts), respectively. The worms were
observed by stereo microscopy at the same magniﬁcation. (C, D) The wt, xrn-2(+) and xrn-2ts worms were cultured from mid L3- to late L4-stage at
15C or 26C and harvested. (C) XRN2, XRN2/GFP and actin protein levels were examined by western blotting. XRN2 and XRN2/GFP levels were
normalized to actin levels and shown with values of wt at 15C deﬁned as 100. (D) The mRNA levels of the xrn-2::gfp transgenes in xrn-2(+) and
xrn-2ts worms were quantiﬁed by RT-qPCR, normalized to actin mRNA levels and shown with values of xrn-2(+) at 15C as 1 (n=2,
means+SEM). ‘xrn-2(+)’ denotes xrn-2(tm3473) homozygous animals expressing a wild-type xrn-2 transgene.
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biogenesis byproducts. It is also consistent with generally
long miRNA half-lives observed in a microarray-based
study that was conﬁned to a survey of annotated
miRs (40).
Speciﬁc miRNAs are stabilized on XRN2 inactivation
Although the fast decay rates were preferentially seen for
miR*s, some miRs exhibited unusually low stability, most
notably several members, though not all, of each of
the miR-35 (miR-35 through miR-42) and the miR-51
(miR-51 through miR-56) families. To test whether this
was due to decay by XRN2, we repeated the a-amanitin
time-course experiment for wild-type and xrn-2ts worms.
Under the conditions that we use, a-amanitin completely
blocks development at the early L1 stage (Supplementary
Figure S2; Supplementary Materials and Methods), so
that wild-type and xrn-2ts animals are equally arrested
in development.
For this analysis, we focused on miRNAs with low sta-
bility (apparent log2 fold change of less than 0.035/h and
thus below the blue cut-off line in Figure 5B) and moder-
ately high, to high, expression levels (>210 normalized
reads, to the right of the cut-off line). We determined
the levels of individual miRNAs by RT-qPCR and
normalized them to sn2841, a small nucleolar RNA
whose level is stable during the time course (data not
shown). When testing the ﬁve rapidly decaying members
of the miR-35 family, all of them displayed comparable
half-lives in wild-type and xrn-2ts animals (Figure 5C and
Supplementary Figure S4). Similarly, xrn-2 inactivation
had little effect on the decay of miR-1, miR-65 and
miR-244. By contrast, the decay of miR-51 and miR-87
was substantially and signiﬁcantly delayed in xrn-2ts
animals. The miR-54, miR-55, miR-56, miR-73 and
miR-243 showed a similar trend, although differences
failed to reach statistical signiﬁcance (Supplementary
Figure S4). We also examined decay of the highly ex-
pressed and unstable miR-54* and found it to be un-
affected by XRN2 inactivation. Similarly, miR-87*,
unlike miR-87, continued to decay rapidly when XRN2
was inactive. As the passenger and guide strand derive
from the same precursor, this directly conﬁrms that the
decreased apparent half-lives of the guide strands truly
reﬂects stabilization of this guide strand and not a second-
ary effect of altered processing of residual pre-miRNAs.
Taken together, our data reveal that XRN2 is essential for
rapid decay of a subset of miRNAs during the ﬁrst larval
stage.
DISCUSSION
xrn-2 is broadly expressed and functions in processes
beyond molting
Although molecular functions of XRN2 proteins have
been studied extensively, particularly in yeast and
cultured human cells, their developmental functions have
remained virtually unexplored (15). An RNAi-based
screen had implicated XRN2 in molting in C. elegans,
consistent also with its expression in tissues important
for cuticle generation or shedding (22), and in agreement
with this idea, we ﬁnd that an xrn-2 null mutation causes a
penetrant L1 molting defect and subsequent L2 stage
arrest. However, by generating a conditional allele, we
could demonstrate that this only represents the tip of the
iceberg; XRN2 in C. elegans is required for numerous
events during embryonic and post-embryonic develop-
ment as demonstrated for instance by embryonic lethality
and sterility under appropriate regimens.
In yeast, where Rat1p/XRN2 is essential for viability,
mutations cause a diverse array of defects in various RNA

















































































































































































































































































































Figure 5. Speciﬁc miRNAs are stabilized on XRN2 depletion.
(A) Experimental design for miRNA decay analysis. RNA was
extracted for (B) deep sequencing and (C) RT-qPCR analyses.
(B) Relative decay rates of miRNAs are plotted against normalized
reads for miRNAs with sufﬁcient expression (‘Materials and
Methods’ section). Black stars, miRs; red stars, miR*s. Fifteen miRs
that showed high-read numbers and fast relative decay as indicated by
the blue cut-off lines. (Because the plot shows fold changes per hour,
not decay constants, unstable miRNAs are those below the cut-off
line.) These and two miR*s, indicated in black, were further
examined by RT-qPCR. Other miRs discussed in the main text are
shown in grey. (C) The miRNA levels at each time point in wt and
xrn-2ts worms were quantiﬁed by RT-qPCR, and their half-lives were
calculated as described in ‘Materials and Methods’ section. Relevant
P-values are shown. ns, not signiﬁcant.
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metabolic processes, such as transcriptional termination,
ribosomal RNA processing, intron degradation and
aberrant transfer RNA degradation (15). However, it
remains to be determined which of these processes consti-
tutes the essential function of Rat1p or whether it is any
one process. Similarly, it remains to be established for
C. elegans whether the requirements for functional
XRN2 in different tissues and developmental stages
reﬂect a core underlying theme, or whether the respective
targets and processes that become dysregulated on XRN2
depletion vary. We also note that although we have
focused here on miRNAs as the only currently known
substrate of C. elegans XRN2, it is highly likely that
numerous additional substrates exist, and any of these,
individually or in combination, may be relevant for the
xrn-2 mutant phenotypes. Nonetheless, our demonstra-
tion that mutations inactivating the XRN2 catalytic site
also abrogate its ability to complement an xrn-2 null
mutation argue that it is processing or degradation
of one or several RNA substrates that are important
for the function of XRN2 in molting. Modulator, i.e.
enhancer and suppressor, screens may offer a way
forward to identify speciﬁc targets and pathways
affected by xrn-2 deﬁciency and have been initiated in
our laboratory.
XRN2 substrate preferences
In vitro, XRN2 proteins can degrade various RNA se-
quences, provided they are 50-monophosphorylated and
devoid of stable structures (9,10). However, we ﬁnd here
that in the L1 stage, only a subset of miRNAs is stabilized
on XRN2 inactivation. We cannot formally rule out that
XRN2 activity at the restrictive temperature is not fully
eliminated in the xrn-2ts strain and that complete loss
of activity would stabilize all miRNAs. Nonetheless,
the available data demonstrate that, minimally, some
miRNAs are more dependent on XRN2 for degradation
than others.
The mechanisms that provide speciﬁcity remain to be
elucidated. On the XRN2 side, the enzyme may either
contain previously unrecognized intrinsic speciﬁcity, or
its substrate range may be restricted speciﬁcally in vivo
through the action of protein binding partners, such as
the newly identiﬁed PAXT-1 (41). Similarly, features of
the miRNA that render them sensitive or insensitive to
XRN2 remain to be identiﬁed. Although we lack enough
examples of miRNAs that are stabilized by mutation
of xrn-2 to conﬁdently comment on the involvement of se-
quence features, we note that there is almost no overlap in
sequence between miR-51 and miR-87, and they even
differ in their 5’ ends, with miR-51 sporting the
miRNA-characteristic U and miR-87 and miR-243 a
more unusual G and C, respectively. Hence, it seems
possible that instead of, or in addition to, sequence, the
site of expression of an miRNA might affect its sensitivity
to degradation by XRN2. Because our expression analysis
of XRN2 indicates widespread, possibly ubiquitous ex-
pression of xrn-2, such a model would imply the existence
of additional factors that either promote degradation of
speciﬁc miRNAs by XRN2 in some tissues or prevent it in
others. Targets of miRNAs might be one such factor. We
previously reported that target RNAs protected their
cognate miRNAs from degradation (16,38). At this
point, it is not known whether any target can do this,
for any miRNA, or if speciﬁc miRNA-target duplex archi-
tectures are required. Nonetheless, differences in the levels
of either the entire group of target RNAs, or only indi-
vidual targets, might thus alter XRN2 activity towards
miRNAs in a tissue-speciﬁc manner.
Finally, intracellular localization of miRNAs may affect
their susceptibility to degradation by XRN2. This notion
is based on our ﬁnding that XRN2 accumulates preferen-
tially, perhaps exclusively in the nucleus [this study and
(42)]. By contrast, miRNAs are thought to function in the
cytoplasm, where they would thus be shielded from XRN2
activity. At the same time, a number of mature C. elegans
miRNAs have recently been detected in both nucleus and
cytoplasm, with individual miRNAs apparently differing
in their nucleocytoplasmic distribution (43). However,
because we have so far been unable to achieve sufﬁciently
clean fractionation of nuclei versus cytoplasm, it remains
to be determined whether XRN2-sensitive miRNAs parti-
tion more extensively to the nucleus than those that are
XRN2-insensitive.
miRs and miR*s differ in their stabilities
Initially, it was assumed that miRNA precursors give rise
to only one functional molecule, the mature miRNA or
guide strand/miR. A second partially complementary
molecule derived from the opposite strand of the pre-
miRNA, the passenger strand/miR*, might be visible at
much lower levels and constitute merely a biogenesis inter-
mediate. More recently, however, several examples of
functional miR*s have been described, and it has
emerged that in some cases the ratio of miR to miR*
may be variable and change with site of expression or
development (18). Accordingly, a different nomenclature
that identiﬁes miRNA molecules based on their proven-
ance from either the 50 or the 30 arm of the pre-miRNA
has been adopted. Although there can be little doubt on
the functionality of certain miR*s, our decay data strongly
suggest that at least in our system most of them accumu-
late only transiently, supporting their designation as
processing intermediates. Although ours is the ﬁrst dem-
onstration of this phenomenon on a global scale, Winter
and Diederichs previously examined the half-lives of a
small number of miRs and miR*s in human cells and
equally observed reduced half-lives of the latter (44).
Moreover, they noted that over-expression of Argonaute
proteins could stabilize two miR*s that were investigated,
suggesting that it is lack of Argonaute loading that renders
miR*s unstable, which would also deprive them of a func-
tional miRNA status.
We note that the least stable of all miRNAs that we
observe is annotated as miR, miR-1824-3p, rather than
miR*. However, deep sequencing is subject to sequence-
dependent biases that prevent exact quantiﬁcation of
distinct small RNAs [(45) and our unpublished data].
The miR-1824-3p displays only marginally (1.6-fold)
more reads than its presumed miR*, miR-1824-5p,
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which is much more stable (log2 fold change of 0.16/h
versus 0.35/h for 5p versus 3p). Hence, we predict that
absolute quantiﬁcation would reveal that miR-1824-5p is
more abundant than miR-1824-3p and thus the true miR
by our criterion.
De novo generation of a conditional xrn-2 allele
Genetic mutations are invaluable tools in assigning
function to genes. However, if a gene has multiple con-
secutive functions in development, it can be difﬁcult or
impossible to study all of them with ‘constitutive’ muta-
tions especially when an early function is essential during
development. At the same time, for essential genes,
homozygously mutant animals by necessity need to be
derived from heterozygous parents, which may contribute
mRNA or protein to their offspring so that early pheno-
types can be masked (46). RNAi may be used to deplete
such maternal mRNAs, but usually results in only partial
depletion of transcripts and protein products. Similarly,
although RNAi may be applied such that an early
terminal phenotype in development is bypassed (47,48),
it can usually not be timed precisely. Although xrn-
2(RNAi) phenocopies the sterile phenotype of xrn-2ts
animals, none of the conditions we tried so far were able
to elicit embryonic lethality.
Conditional alleles, encoding rapidly inactivatable gene
products, would permit addressing both of the aforemen-
tioned issues. The ts alleles are widely used for instance in
yeast, and screens have been conducted in C. elegans to
identify ts alleles for speciﬁc processes. However, because
it has not been possible to predict a priori which muta-
tions will generate a ts allele, targeted approaches for gen-
eration of conditional alleles of speciﬁc genes have been
lacking.
We provide here proof of principle that a C. elegans ts
mutation can be generated de novo by exploiting informa-
tion from a different organism, yeast, despite major dif-
ferences in their physiological temperature ranges. We
note that our approach is not easily scalable and its gen-
erality remains to be established. However, many yeast ts
alleles exist, and new ones can easily be generated, e.g. by
complementing yeast deletion mutant cells with randomly
mutagenized transgenes expressing the genes of interests.
Hence, ours may be a fertile approach for other re-
searchers interested in generating conditionally mutant
C. elegans strains, complementing transcriptional
(49,50), co-transcriptional (51) or post-transcriptional
(52) approaches that modulate mRNA levels and thus,
indirectly, protein activity.
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